Pyng Medical Corp (PYT)

Currency in CAD
0.3950
0.0000(0.00%)
Closed·
Showing Pyng Medical historical data. For real-time data please try another search
Day's Range
0.39500.3950
52 wk Range
0.00000.3950
Key Statistics
Bid/Ask
0.395 / 0.40
Prev. Close
0.395
Open
0.395
Day's Range
0.395-0.395
52 wk Range
0-0
Volume
-
Average Volume (3m)
144.17K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Pyng Medical Corp Company Profile

Pyng Medical Corp. develops, engineers, and markets trauma and resuscitation products for front-line critical care personnel worldwide. Its product portfolio comprises sternal intraosseous, pelvic stabilization, and tourniquet devices. The company offers FAST1 intraosseous infusion system, which enables the administration of drugs, medications, fluids, and blood to patients that require emergency life-saving treatment; and FASTResponder and FASTCombat sternal intraosseous devices that deliver fluids, medication, and blood easily. It also provides T-PODResponder and T-PODCombat pelvic stabilization devices for the treatment of simple and complex pelvic by binding pelvis to reduce pain, bleeding, and hemorrhage, as well as morbidity and mortality risks; E-MAT and MAT Tourniquet that is applied by the wounded patient or initial responder stops life threatening bleeding to reduce the risk of limb loss and mortality; and MATResponder, which provides first responders with safe compression in controlled increments. In addition, the company offers complete rapid illuminated cricothyrotomy, a life-saving medical product allowing for one-handed surgical airway intervention; and FASTTactical, a sternal intraoseous infusion device. It markets its products to hospital staff, emergency medical services, and military forces. Pyng Medical Corp. is based in Richmond, Canada. Pyng Medical Corp. operates as a subsidiary of Teleflex Incorporated.

Earnings

Latest Release
Feb 27, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PYT Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.